Extended-Release Carbamazepine Capsules: In Bipolar I Disorder

By Tracy Swainston Harrison   Keating Gillian M.  

CNS Drugs, Vol. 19, Iss. 8, 2005-01 ,pp. : 709-716

Adis International

Access to resources Recommend Favorite

Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan

By Nakamura Yu   Kitamura Shin   Homma Akira   Shiosakai Kazuhito   Matsui Daiju  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 913-925

Informa Healthcare

Access to resources Recommend Favorite

Extended-Release Carbamazepine Capsules in Bipolar I Disorder: Profile Report

By Tracy Swainston Harrison   Keating Gillian M.  

American Journal of Drug Delivery, Vol. 4, Iss. 1, 2006-01 ,pp. : 51-55

Adis International

Access to resources Recommend Favorite

Effects of Adalimumab versus Placebo on Risk of Symptom Worsening in Psoriasis and Subsequent Impacts on Health-Related Quality-of-Life: Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled, Multicentre Clinical Trials

By Papp Kim A.  

Clinical Drug Investigation, Vol. 31, Iss. 1, 2011-01 ,pp. : 51-60

Adis International

Access to resources Recommend Favorite

Gabapentin Extended-Release Tablets for the Treatment of Patients with Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled, Multicentre Study

By Wallace Mark S.  

Clinical Drug Investigation, Vol. 30, Iss. 11, 2010-11 ,pp. : 765-776

Adis International

Access to resources Recommend Favorite